Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.28 0.00 (-0.25%)
As of: Oct 2, 2026 · 10:58 AM EDT

Vistagen Therapeutics (VTGN) Return on Assets [ROA] (2012 - 2026)

Updated

Vistagen Therapeutics (VTGN) recorded Return on Assets [ROA] of -160.48% in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 87.69 percentage points from -72.79% a year earlier and down 37.78 percentage points from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Return on Assets [ROA] (2012 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Vistagen Therapeutics reported Return on Assets [ROA] of -104.90%, down 55.46 percentage points from FY2025.

  • Annual Return on Assets [ROA] has a five-year change of -73.45 percentage points (FY2021 to FY2026).
  • Across earlier fiscal years, Return on Assets [ROA] came in at -49.44% in FY2025 (-8.87 pp), -40.57% in FY2024 (+83.21 pp), -123.78% in FY2023 (-71.56 pp) and -52.22% in FY2022 (-20.77 pp).
  • The fiscal Q1 2027 figure is the lowest quarterly Return on Assets [ROA] since fiscal Q1 2024.
  • On a year-over-year basis, Return on Assets [ROA] has declined for seven consecutive quarters, with an average year-over-year change of -30.76 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 228.78 percentage points in fiscal Q1 2025, against a drop of 175.44 percentage points in fiscal Q4 2023 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at -122.70% (Q4 2026), -91.85% (Q3 2026) and -83.06% (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Vistagen Therapeutics 13.76 Mn 13.76 Mn - -160.48%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -160.48%
Mar 31, 2026 -122.70%
Dec 31, 2025 -91.85%
Sep 30, 2025 -83.06%
Jun 30, 2025 -72.79%
Mar 31, 2025 -58.22%
Dec 31, 2024 -48.57%
Sep 30, 2024 -36.63%
Jun 30, 2024 -27.99%
Mar 31, 2024 -23.05%
Dec 31, 2023 -37.02%
Sep 30, 2023 -123.99%
Jun 30, 2023 -256.77%
Mar 31, 2023 -233.27%
Dec 31, 2022 -180.96%
Sep 30, 2022 -129.71%
Jun 30, 2022 -89.67%
Mar 31, 2022 -57.83%
Dec 31, 2021 -39.03%
Sep 30, 2021 -31.36%
API Access

Vistagen Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=VTGN&period=max&api_key=YOUR_API_KEY